IXICO plc (PHYOF) Financials

PHYOF Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 17.2 million 3.0 million
Sept. 30, 2025 18.6 million 2.8 million
March 31, 2025 18.2 million 2.3 million
Sept. 30, 2024 15.0 million 2.3 million

PHYOF Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -1.8 million ?
Sept. 30, 2025 -2.3 million 186856
March 31, 2025 -249721 113862
Sept. 30, 2024 -722277 ?

PHYOF Net Income

No data available :(

PHYOF Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 2.2 million - 594223
Sept. 30, 2025 4.8 million - 240628
March 31, 2025 6.5 million - 355821
Sept. 30, 2024 2.4 million - 419991

PHYOF Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 122.3 million
Sept. 30, 2025 120.3 million
March 31, 2025 111.6 million
Sept. 30, 2024 64.7 million

PHYOF Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 160135 1.0 million 3.3 million -
Sept. 30, 2025 1.1 million 943694 2.7 million 1.1 million
March 31, 2025 28465 809978 2.8 million 1.1 million
Sept. 30, 2024 13375 955011 2.6 million -

PHYOF Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 5.2 million 2.6 million
Sept. 30, 2025 4.5 million 2.3 million
March 31, 2025 4.2 million 2.1 million
Sept. 30, 2024 4.3 million 2.2 million

PHYOF

Price: $0.77

52 week price:
0.07
0.77

Earnings Per Share: -0.05 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 6.5 million

Links: